The ASST Bergamo Ovest and the San Gerardo dei Tintori Foundation are implementing extraordinary vaccination clinics in Lombardy, Italy, to mark World Vaccination Week (April 24-30, 2026). These initiatives aim to close immunity gaps and increase vaccine uptake across diverse patient demographics to prevent avoidable infectious outbreaks.
Although local clinics in Bergamo and Monza focus on accessibility, this movement reflects a broader global imperative. Vaccination is not merely a personal health choice but a critical component of herd immunity—the point where a sufficient percentage of a population is immune to an infectious disease, making its spread unlikely. When regional health authorities like the ASST (Azienda Socio Sanitaria Territoriale) create “extraordinary sessions,” they are addressing vaccine hesitancy, a psychological and social barrier that often leads to the resurgence of eradicated diseases.
In Plain English: The Clinical Takeaway
- Closing the Gap: These special clinics are designed to make it easier for people who missed their scheduled shots to get updated.
- Community Shield: Higher vaccination rates in specific areas like Bergamo protect vulnerable people (like newborns or cancer patients) who cannot be vaccinated.
- Prevention over Cure: It is statistically safer and more effective to prevent a virus via vaccination than to treat the complications of the disease after infection.
The Epidemiological Imperative: Why Lombardy is Scaling Up
The decision by the ASST Bergamo Ovest to hold extraordinary sessions is a response to a measurable decline in routine immunization coverage. In public health, we track the Basic Reproduction Number (R0), which represents the average number of people one infected person will infect in a completely susceptible population. When coverage drops below the critical threshold—often 95% for highly contagious pathogens like measles—the R0 increases, risking localized epidemics.
This initiative aligns with the European Medicines Agency (EMA) guidelines and the Italian National Vaccine Prevention Plan. By decentralizing access, the healthcare system reduces the “friction” of medical appointments, which is a primary driver of non-compliance in adult populations. The focus is not only on pediatric schedules but on catch-up vaccinations for adults who may have missed boosters for Tetanus, Diphtheria, and Pertussis (Tdap).
“Vaccines are the most cost-effective public health intervention available. The challenge today is not the lack of science, but the gap in delivery and the erosion of trust. Regional efforts to bring vaccines directly to the community are essential to maintaining global health security.” — Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO)
Mechanism of Action: How Modern Vaccines Prime the Immune System
To understand why these clinics are vital, one must understand the mechanism of action—the specific biochemical process through which a drug or vaccine produces its effect. Most vaccines utilized in these campaigns operate by introducing an antigen (a weakened or inactive part of a particular virus or bacteria) into the body.
This triggers the production of antibodies and the creation of memory B-cells. If the actual pathogen ever enters the body, the immune system recognizes it immediately and neutralizes it before it can cause systemic illness. This is a prophylactic measure, meaning it is intended to prevent disease rather than treat an existing infection.
The funding for these large-scale public health campaigns in Italy is primarily government-funded through the National Health Service (SSN), ensuring that the vaccines are provided free of charge to the public. This removes the socioeconomic barrier to entry, which is a critical factor in achieving equitable health outcomes.
| Vaccine Type | Target Pathogen | Typical Efficacy Rate | Primary Goal |
|---|---|---|---|
| mRNA / Viral Vector | SARS-CoV-2 / Influenza | 70% – 95% | Prevention of severe disease/death |
| Live Attenuated | MMR (Measles, Mumps, Rubella) | >97% | Long-term systemic immunity |
| Toxoid / Inactivated | Tetanus / Polio | 90% – 100% | Prevention of toxin-mediated illness |
Bridging the Gap: From Local Clinics to Global Policy
The efforts in Bergamo and Monza are microcosms of a global strategy coordinated by the World Health Organization (WHO). In the United States, the CDC manages the Vaccines for Children (VFC) program to ensure similar access. In the UK, the NHS utilizes a centralized registry to send reminders, a digital strategy that Italy is increasingly adopting to reduce “dropout rates” between the first and second doses of multi-shot series.
The statistical probability of an outbreak increases significantly when “pockets” of unvaccinated individuals form. This is known as clustering. Even if a city has a 90% overall vaccination rate, if one neighborhood is only 60% vaccinated, that area becomes a high-risk zone for an outbreak that can then spread to the rest of the city.
Contraindications & When to Consult a Doctor
While vaccines are rigorously tested for safety, they are not universal. Contraindications—specific situations in which a drug or treatment should not be used because it may be harmful to the patient—exist for every vaccine.
- Severe Allergies: Individuals with a history of anaphylaxis (a severe, life-threatening allergic reaction) to a specific vaccine component (e.g., gelatin or egg protein) must consult an allergist.
- Immunocompromised States: Patients undergoing chemotherapy or those with advanced HIV/AIDS should avoid live attenuated vaccines, as their immune system may not be able to handle even a weakened virus.
- Acute Illness: If you have a high fever or a severe systemic infection, it is generally advised to postpone vaccination until recovery to avoid confusing the symptoms of the illness with vaccine side effects.
When to seek immediate care: While mild soreness at the injection site is common, seek emergency medical attention if you experience difficulty breathing, swelling of the throat, or a rapid heart rate immediately following an injection.
The Future of Preventative Immunology
As we move past the 2026 World Vaccination Week, the trajectory of public health is shifting toward personalized immunization. We are seeing a move toward adjuvanted vaccines—vaccines that include an ingredient to create a stronger immune response—which are particularly effective for the elderly whose immune systems are naturally waning (a process called immunosenescence).
The extraordinary sessions in Bergamo Ovest are more than just a calendar event; they are a necessary intervention to maintain the fragile wall of public health. By combining clinical accessibility with evidence-based communication, we can move from a reactive healthcare model to a proactive one.
References
- PubMed Central (National Library of Medicine)
- The Lancet – Infectious Diseases
- Centers for Disease Control and Prevention (CDC)
- World Health Organization (WHO) Global Vaccine Action Plan
- European Medicines Agency (EMA)
Disclaimer: This article is for informational purposes and does not constitute individual medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
